Medication info
Raprin Tablet 20 mg (Rabeprazole Sodium)

Raprin Tablet 20 mg (Rabeprazole Sodium)

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›20mg / 1 tablet
Manufacturer / importer
Taegeuk Pharmaceutical Co., Ltd.
Appearance
Pale yellow, round enteric-coated tablet
Packaging
28 tablets (14 tablets/PTP × 2)
Approval status
Active

MFDS item code 201901743 · Approved 2019.03.22

Summary

Main use
Treatment of gastroesophageal reflux disease, peptic ulcers (including as part of eradication therapy), and Zollinger-Ellison syndrome
Who takes it
Adults · Children
Adult dose
Gastric ulcer, duodenal ulcer: The usual adult dose is rabeprazole sodium 10 mg orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI, proton pump inhibitor), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, the 20 mg twice-daily dose is for patients with confirmed severe mucosal damage only. Symptom relief of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms resolve, subsequent symptoms may be controlled, as needed, using on-demand therapy with 10 mg once daily. Long-term maintenance therapy for gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients with Helicobacter pylori infection should receive eradication therapy. It is recommended to administer this medicine 20 mg, clarithromycin 500 mg, and amoxicillin 1 g together twice daily for 7 days. Zollinger-Ellison syndrome: The recommended initial adult dose is 60 mg once daily. The dose may be adjusted up to 120 mg daily according to each patient's needs. Doses up to 100 mg may be administered once daily; the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this medicine for up to 1 year. ○ Patients with hepatic impairment Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. ○ Older adults Use with caution, as hepatic function is often decreased.
Child dose
Safety in children has not been established.

Ingredients

Manufacturer
Taegeuk Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, peptic ulcers (including as part of eradication therapy), and Zollinger-Ellison syndrome

  • Gastric ulcer
  • duodenal ulcer
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • symptoms of gastroesophageal reflux disease
  • gastrointestinal ulcers
  • Zollinger-Ellison syndrome
View approved original text

This medication is used to treat gastric ulcers and duodenal ulcers, and to relieve the symptoms of erosive or ulcerative gastroesophageal reflux disease. It is also effective for long-term maintenance therapy of gastroesophageal reflux disease. In patients with gastrointestinal ulcers infected with Helicobacter pylori, it can be used in combination with antibiotics. It is also beneficial for Zollinger-Ellison syndrome. In summary, this medicine is used to treat gastrointestinal ulcers and gastroesophageal reflux disease and related conditions.

How to take

Adult dose

Gastric ulcer, duodenal ulcer: The usual adult dose is rabeprazole sodium 10 mg orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI, proton pump inhibitor), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, the 20 mg twice-daily dose is for patients with confirmed severe mucosal damage only. Symptom relief of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms resolve, subsequent symptoms may be controlled, as needed, using on-demand therapy with 10 mg once daily. Long-term maintenance therapy for gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients with Helicobacter pylori infection should receive eradication therapy. It is recommended to administer this medicine 20 mg, clarithromycin 500 mg, and amoxicillin 1 g together twice daily for 7 days. Zollinger-Ellison syndrome: The recommended initial adult dose is 60 mg once daily. The dose may be adjusted up to 120 mg daily according to each patient's needs. Doses up to 100 mg may be administered once daily; the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this medicine for up to 1 year. ○ Patients with hepatic impairment Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. ○ Older adults Use with caution, as hepatic function is often decreased.

Child dose

Safety in children has not been established.

Precautions

This medication should not be given to patients with known hypersensitivity to any of its components or a history of allergic reactions. Additionally, it should not be used by pregnant or nursing women. Caution is advised in patients with liver dysfunction or the elderly, since adverse reactions may occur. If any hypersensitivity symptoms such as skin rash, itching, or hives occur while taking this medication, it should be discontinued immediately. It is important to have regular blood tests and liver function tests to check for any unusual signs. Since this medication suppresses gastric acid secretion, prolonged use may lead to side effects like osteoporosis or hypomagnesemia. There may also be a slight increased risk of gastrointestinal bacterial infections, so if diarrhea persists, consult a healthcare professional. This medication may interact with other drugs, so always inform your healthcare provider of any other medications you are taking. Caution is required when driving or operating machinery, as drowsiness may occur. In the case of overdose, there is no specific antidote, and appropriate treatment should be given based on symptoms. This medication should be swallowed whole without chewing or crushing, and kept out of the reach of children.

Side effects

Rash, urticaria, itching, erythrocytopenia, leukopenia, leukocytosis, eosinophilia, neutrophilia, lymphocytopenia, anemia, petechiae, lymphadenopathy, hypochromic anemia, pancytopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, ALT elevation, AST elevation, ALP elevation, γ-GTP elevation, LDH elevation, total bilirubin elevation, fulminant hepatitis, liver dysfunction, jaundice, hypertension, myocardial infarction, abnormal electrocardiogram, migraine, syncope, angina pectoris, block of conduction, palpitations, bradycardia, tachycardia, pulmonary embolism, ventricular tachycardia, thrombophlebitis, vasodilation, prolonged QT interval, ventricular tachyarrhythmia, diarrhea, constipation, abdominal pain, abdominal bloating, dyspepsia, belching, nausea, rectal bleeding, bloody stools, anorexia, cholelithiasis, oral ulceration, dysphagia, gingivitis, cholecystitis, increased appetite, abnormal stools, colitis, esophagitis, glossitis, pancreatitis, proctitis, thirst, vomiting, lower abdominal pain, gastric body, gastritis, stomatitis, taste abnormalities, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatic encephalopathy, hepatitis, liver cancer, hepatic steatosis, sialadenosis, thirst, headache, insomnia, anxiety, dizziness, convulsions, abnormal dreams, decreased libido, neuropathy, sensory abnormalities, tremors, weakness, neuroexcitation, drowsiness, vertigo, depression, agitation, amnesia, confusion, extrapyramidal syndrome, excessive blood flow volume, limb weakness, sensory impairment, decreased grip strength, language confusion, staggering, delirium, spatial disorientation, hypersomnia, cough, pharyngitis, rhinitis, dyspnea, asthma, nosebleed, laryngitis, hiccups, hyperventilation, bronchitis, sinusitis, apnea, respiratory depression, interstitial pneumonia, myalgia, low back pain, arthritis, leg cramps, bone pain, arthrosis, bursitis, hypertonic muscle syndrome, neuralgia, single contraction, sweating, alopecia, dry skin, herpes zoster, psoriasis, skin color change, toxic epidermal necrolysis, mucous membrane disorders, erythema multiforme, cataract, amblyopia, glaucoma, dry eye, abnormal vision, tinnitus, otitis media, corneal opacity, blurred vision, double vision, hearing loss, eye pain, retinal degeneration, strabismus, proteinuria, cystitis, frequency of urination, dysmenorrhea, dysuria, nephrolithiasis, uterine bleeding, polyuria, breast enlargement, hematuria, erectile dysfunction, vaginal discharge, menorrhagia, orchitis, urinary incontinence, interstitial nephritis, edema, total cholesterol elevation, triglyceride elevation, BUN elevation, blood thyroid-stimulating hormone elevation, chest pain, chills, fever, urinary tract infection, erythema, fatigue, weight gain, visual disturbances, loss of appetite, neck stiffness, phototoxic reactions, hangover effects, weight loss, gout, anaphylactic reactions, shock, hepatitis, jaundice, hepatic encephalopathy, sudden death, coma, hyperammonemia, rhabdomyolysis, delirium, vascular edema, hypomagnesemia, thrombocytopenia, neutropenia, vesicular skin rash, systemic allergic reactions, arthralgia, interstitial nephritis, gynecomastia, thyroid-stimulating hormone elevation, visual impairment, fracture, Clostridium difficile diarrhea, systemic lupus erythematosus, cutaneous lupus erythematosus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be kept in a tightly closed container to protect it from air and moisture, and it is best stored at room temperature between 1 and 30 degrees Celsius. This will help maintain the effectiveness of the medication.

Appearance and packaging

Appearance

Pale yellow, round enteric-coated tablet

Package unit

28 tablets (14 tablets/PTP × 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.